Go To TTD's Pre-Market Opening Breakout Watch Stock Lists for Monday, April 27
|
Go To TTD's Pre-Market Opening Breakout Watch Stock Lists for Monday, April 27 |
| Go to Video Show - "How to Make Money With Breakout Stocks" |
|
Go to Video Show - "How to Make Money With Breakout Stocks" |
|---|
Ticker Tape Digest presents its daily breakout and Short Selling report.
It contains Breakout Stocks and Stocks under Significant Accumulation. 
Data is from tape action for the day. These stocks are most suitable for aggressive investors seeking ideal entry points for leading stocks.
These stocks will do very well during bull markets and strong market rallies.
TTD also presents Stocks To Sell or Sell Short. These issues are suitable for aggressive investors willing to take short positions both as trades or for longer-term plays. These stocks
will do very well during bear markets or market corrections
TTD's multi-media updates include a slide-show that presents charts and analysis at midsession. Some times TTD presents feature analysis on stocks and the market. TTD uses Windows Media Files. (WMV).
TTD also presents a "Breakout Watch List" that is up dated daily. This list consists of key stocks in position to breakout. A close watch of this list can put you in the stock just as it breaks out.
TTD often suggests using stop buy orders to enter. It is very important to buy a breakout stock as close as possible to the break point. The idea is to get "elbow room" if the stock should follow through to the upside. This is very important in being successful in making big money with breakout stocks.
TTD also has special feature sections on Educational Tips on Investing.
To email Mr. Leo Fasciocco leo@tickertapedigest.com.For service, email Beverly Owen owen@tickertapedigest.com. TTD’s Tel: 1-480-926-1680.
Stocks Screened - 8,200
Bull's Strategy - Breakout list small today as market sells off. Bulls be more venturesome, but try to go with stocks near 52- highs and with good earnings outlooks.
(Put mouse on Dow chart to see Nasdaq chart)
Long Term Environment for bulls: Neutral
Market (Daily) - NYSE Bullish, Nasdaq Bullish
Market (Weekly) -NYSE Bullish, Nasdaq Bullish
Market (Monthly) NYSE Bullish, Nasdaq Bullish
| TTD's Quality Rating of Stock - IMA - AVERAGE |
IMA, based in Waltham, Ma., develops and markets consumer and professional point-of-care diagnostic devices and nutritional supplements. Annual revenues: $1.7 billion. IMA's stock streaks higher today after the company reported a bullish surprise with earnings. The stock breaks out from an 11-week, cup-and-handle base. It is a laggard though and well off its all-time higher. Nevertheless, the earnings surprise could carry it higher.
TTD highlighted IMA as a breakout at our midsession show on the Web today.
So far today, IMA is trading up about 3 points. Volume is running at 3.1 million shares, triple its normal daily volume of 849,000 shares. The strong volume on the breakout is very bullish.
IMA drove higher in the morning and then trended sideways the rest of the day. TTD's clip of the tape shows a big block of 22,700 shares crossing on a big up tick to $29.62 from the prior trade at $29.51. The tape action showed aggressive institutional buying interest.
IMA's devices target the cardiology, oncology, drug abuse, and women's health arenas. Since 2007, the firm entered the health services market and became the second-largest health management provider in the United States.
Today, IMA reported first quarter earnings increased to 64 cents a a share from one cent a year ago. The 64 cents topped the consensus Street estimate of 53 cents a share, which was also the highest estimate on the Street. TTD has pointed out that when a company can top the highest quarterly estimate on the Street, the stock can often move higher on the news and trend higher for the next few weeks. TTD sees that potential with IMA.
TTD's performance chart shows that IMA's stock has appreciated 85% the past 12 months. It has easily outperformed the S&P 500 index which is down 10%.
TTD's long-term chart shows IMA with a big run up from 23 in 2006 to a peak of 65 in 2007. The stock then went into a bear market. It has now turned up and has good prospects to work higher.
IMA's daily chart shows the breakout today which comes on a widening of the spread. That is bullish showing ease of price movement. Volume today is strong.
The stock's TTD momentum indicator (top of the chart) is slightly bullish.
The accumulation - distribution line has turned up. The general stock pattern going back to December is very bullish. It shows IMA in a solid up trend, with one basing pause.
IMA's strong first quarter reflected an increase in revenues to $443 million from $372 million a year ago. The jump in revenues reflected acquisitions.
Adjusted net for the quarter was 61 cents a share compared with 48 cents a year ago.
Looking out to the second quarter, analysts project a 51% increase in net to 56 cents a share from 37 cents a year ago. So, the company should show continued strong profits.
Net for the year is expected to increase 18% to $2.32 a share from $1.97 a year ago. The estimate for the year could be bumped up. The stock sells with a price earnings ratio of just 13. TTD sees that as low and attractive to value investors. Going out to 2010, the Street sees net clmbing 18% to $2.77 a share.
Strategy Opinion: IMA's breakout looks very good. TTD is targeting the stock for a move to 37 within the next few months or sooner. A protective stop can be set near 28. TTD rates IMA a good intermediate-term play provided earnings meet or top expectations.
Sponsorship: Very Good. The largest fund buyer recently was American Funds Growth Fund of America, 4-star rated, which purchased 2.7 million shares. The largest fund holder is American Funds New Economy which holds a 3.7% stake. The fund has a 3-star rating. IMA has 78 million shares outstanding. Funds hold 27 million shares.
Insider Activity: Neutral. Some buying with stock options followed by selling. Six analysts follow the stock and all have a strong buy. Wow!
Stock Performance Chart for 6 months with Quarterly Earnings Markers.
|
TTD's Profile Rating Inverness Medical Innnovations Inc. - (IMA) |
| TTD Check List | Bullish | Bearish | Neutral |
| Near 52-week High | YES | ||
| Volume Expansion | YES | ||
| Tick Volume | YES | ||
| Price Trend - Daily | YES | ||
| Price Trend - Long Term | YES | ||
| Price Daily Spread | YES | ||
| Base Structure | YES | ||
| Base - A-D | YES | ||
| Earnings-Quarterly | YES | ||
| Earnings-Long Term | YES | ||
| Earnings Outlook | YES | ||
| Industry Group | YES | ||
| Prior Breakout Success | YES | ||
| Fund Sponsorship | YES | ||
| Total Score | 11 | 0 | 3 |
(The “breakout List” gives all stocks breaking out of a base of five weeks or more. These stocks have a good chance to trend higher. However, a stop should be used to avoid those that do not work. (Trading strategy: One should buy breakout stocks at breakpoint by using market order or stop buy.
Charts of Breakout Stocks
| TTD's Quality Rating of Stock - QCOM - BELOW AVERAGE |
| TTD's Quality Rating of Stock - ANCI - AVERAGE |
Ticker Tape Digest’s Daily List of “Stocks To Sell or Sell Short” ranks stocks well timed to be sold immediately based on daily trading. The list can be used as an alert to reduce current long-term positions.
Shorts from tape action so far today - 3
Stocks Screened - 8,200
Long-Term Environment for bears: Neutral
Bear Side - Just a few breakdown stocks today as stock market backs off slightly. Bears be patient and selective.
(Trading strategy: These stocks can be sold short, or if held should be sold. If a stock is sold short, a protective stop buy should be placed. Short plays work best when the stock market is in a down trend.)
XNPT, based in Santa Clara, Ca., reformulates current market drugs as innovative, more effectively absorbed drug candidates. Annual revenues: $42 million. XNPT's stock falls sharply today after its neuropathy drug failed its trial. The stock gaps lower on big volume. The stock has been in a down trend since peaking at 66 in January of last year. TTD sees more on the downside. 
XNPT is trading a heavy 867,117 shares so far today. That's four times its normal daily volume of 229,000 shares.
XNPT gapped lower at the opening. It lifted slightly afterwards, but then faded a bit in the afternoon. TTD's clip of the tape shows a big block of 18,100 shares crossing on a down tick to $15.37 from the prior trade at $15.39. The tape action indicated clear instiutional selling pressure.
XNPT has three product candidates undergoing clinical trials and another in preclinical development. XP13512 targets both RLS and neuropathic pain, and XP19986 aims to treat acid reflux disease.
The company has a potentially lucrative partnership with GlaxoSmithKline to develop and market XP13512. The firm experienced a setback when XP19986 produced disappointing Phase II results.
This year, analysts expect XNPT to show a loss of $2.68 a share compared with a loss of $2.48 a share a year ago.
TTD's chart shows XNPT's stock fallling sharply and cutting below technical support at $17.25. The stock has been in a clear down trend for several months. TTD sees another leg down.
Strategy Opinion: TTD is targeting XNPT for a decline to 12 within the next few months, or sooner. A protective stop buy can be placed near 16.50.
TTD columnist Leo Fasciocco has covered the stock market for over 20 years. His articles appear in many publications. He is also a speaker at the Intershow conferences. He has been on television and radio. He is author of many educational articles about stock investing and the book “Guide To High-Performance Investing.”
For information to subscribe to the Ticker Tape Digest Services call: B. J. Owen at 1-480-926-1680. Distributed by Corona Publishing Enterprises. Ticker Tape Digest Inc. P.O. Box 2044 Chandler, Az. 85244-2044. TTD “Professional Report” is available on the World Wide Web: $100 per month. Password needed. “TTD Professional“ Faxed is $200 per month. The TTD Daily Report is $39.95. Credit cards accepted.
(The information contained has been prepared from data deemed reliable but there is no guarantee of complete accuracy. Ticker Tape Digest Inc. is not affiliated with any broker, dealer or investment advisor. Nothing in this publication constitutes an offer, recommendation or solicitation to buy or sell any securities. Further research is advised. This report is copyrighted and no redistribution is permitted with out permission. Some of the charts are from Telescan, Insight Trading, First Alert and other sources.)
